Recruiting at 1 site Phase 4 Asthma

Asthma study: Albuterol Sulfate vs Albuterol-Budesonide

Official title Ventilation and Perfusion in Asthmatics

ClinicalTrials.gov ID: NCT07426458

What this study is testing

What is Albuterol Sulfate?

an investigational inhaled bronchodilator being studied for asthma is designed to relax airway smooth muscle by stimulating beta-2 receptors

Also referred to as Ventolin Hydrofluoroalkane (HFA).

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study is testing whether an inhaled corticosteroid and a fast‑acting beta‑antagonist change how air moves in the lungs of adults with asthma.
Who it's for
You may be able to join if you are an adult with asthma.
What's involved
You will use an inhaled steroid and a fast‑acting inhaler. You will have special scans that measure air flow in different parts of your lungs.
Time commitment
The study involves a few visits over a short time, each with the lung scans.
  • Phase 4: studies an already-approved treatment

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 75

You may be able to join if

  • Physician diagnosis of asthma
  • Baseline Forced Expiratory Volume in 1 Second (FEV1) \< 80% of predicted, with reversibility (10%) on post-bronchodilator spirometry
  • Adults, 18-75 years of age
  • Long-term inhaled controller medication consisting of or including an Inhaled corticosteroids (ICS) at a steady dose for at least 3 months before...

You likely can't join if

  • Current cigarette smoking or a past history of \>10 pack-year smoking
  • Current nicotine vaping
  • Pregnant and breast-feeding women
  • Respiratory infection within 4 weeks of proposed study date
  • Forced Expiratory Volume in 1 Second (FEV1) \< 50%
  • Inhaled corticosteroids (ICS)/fast-acting beta agonist (FABA) intolerance
See the full eligibility criteria
Who can join
  • Physician diagnosis of asthma
  • Baseline Forced Expiratory Volume in 1 Second (FEV1) \< 80% of predicted, with reversibility (10%) on post-bronchodilator spirometry
  • Adults, 18-75 years of age
  • Long-term inhaled controller medication consisting of or including an Inhaled corticosteroids (ICS) at a steady dose for at least 3 months before enrollment
What rules you out
  • Current cigarette smoking or a past history of \>10 pack-year smoking
  • Current nicotine vaping
  • Pregnant and breast-feeding women
  • Respiratory infection within 4 weeks of proposed study date
  • Forced Expiratory Volume in 1 Second (FEV1) \< 50%
  • Inhaled corticosteroids (ICS)/fast-acting beta agonist (FABA) intolerance
  • Use of beta-blockers
  • Use of systemic glucocorticosteroids or oral methyl-xanthines within 30 days of planned study visit.

The study team makes the final eligibility decision.

Where it is enrolling

  • Miami, Florida, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Miami, Florida, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.